Hearing Abnormality: Clinical Trials

3 trials for Hearing Abnormality, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Withdrawn 1
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Hearing Abnormality: new trials by email Literature Review of Hearing Abnormality trials Research Report on Hearing Abnormality

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially)
Phase 1 / Phase 2RecruitingUniversity of Colorado, Denver3442025-03-312026-04-30
Validation of a Smartphone-Based Hearing-in-Noise Test (HearMe)
HearMe Smartphone Application - Hearing Loss, Hearing Disorders
Not applicableWithdrawnUniversity of Iowa2021-08-012021-07-28
Optimisation of Hearing Aid Fitting
Objective speech response detection - Hearing Loss, Hearing Abnormality
CompletedUniversity of Southampton202017-12-222021-07-30

Narrower conditions

Hearing Loss (3)  ·  Hearing Disorders (2)  ·  Auditory Diseases, Central (1)  ·  Hearing Loss, Hidden (1)  ·  Hearing Loss, Noise-Induced (1)  ·  Hearing Loss, Sensorineural (1)  ·  Language Development Disorders (1)  ·  Presbycusis (1)  ·  Tinnitus (1)

Broader conditions

Ear Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sensation Disorders (3)  ·  Signs and Symptoms (3)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication Disorders (1)  ·  Hearing Disorders (1)  ·  Language Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Retrocochlear Diseases (1)

Interventions

Clemastine (1)  ·  Placebo Effect (1)

Sponsors

University of Colorado, Denver (1)  ·  University of Iowa (1)  ·  University of Southampton (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Achim Klug, PhD (1)  ·  Samuel A Budoff, PhD, MS (1)  ·  Steven L Bell, Dr (1)

Results publications

PMID 29757799, PMID 30675827, PMID 32317951